BioSpace News Archive

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine, Ad26

Wolters Kluwer, Health , a leading global provider of information and point of care solutions for the healthcare industry, has joined forces with the American Diabetes Association (ADA) and other collaborators to develop and virtually host its 80th Scientific Sessions: A Virtual Experience from June 12 through 16. The ADA’s annual, in-person meeting has been transformed into a fully digital experience leveraging com

Twenty One Additional Self-Swab Testing Sites to Open Across Michigan, New Hampshire, New Jersey, New York, Ohio, Pennsylvania and Virginia

Joint Program Launched by Reagan-Udall Foundation for the FDA and Friends of Cancer Research Delivers Real World Understanding of COVID-19

Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, and Alligator Bioscience AB (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy,

Dimer LLC announces that it has entered into an exclusive, worldwide strategic partnership with Honeywell International Inc. to bring germicidal UV lighting technology to the Aerospace industry.

Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today that it has completed the patient enrollment in its Phase 2 trial to evaluate the efficacy and safety of Thykamine™

Dr. Samadi — currently the Director of Men’s Health and Urologic Oncology at St. Francis Hospital in Roslyn, New York — will report and discuss on the latest in medicine and prevention, as well as news developments related to the coronavirus, on Newsmax TV, America’s fastest-growing cable news network.

Menarini Group, a privately held Italian pharmaceutical and diagnostics company, today announced that is has successfully completed the acquisition of Stemline Therapeutics Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that Michael Hunkapiller, Ph.D. is retiring as Chief Executive Officer and President by the end of the year. Dr. Hunkapiller plans to remain on the Board of Directors. The company als